In another clinical trial, adults with obesity or overweight lost an average of 25.3% of body weight while taking tirzepatide for 88 weeks
Specifically, heart attack rate was 44% lower, stroke rate was 63% lower, rate of cardiac death was 45% lower, and rate of peripheral artery disease requiring amputation was 43% lower with omega-3 fatty acids than placebo (corn oil)
Rheumatoid arthritis and metabolic syndrome
GHK-Cu is understood to act as both a signaling and a carrier peptide, being released at sites of inflammation or tissue injury, where it promotes synthesis of collagen, elastin, proteoglycans, and glycosaminoglycans while exerting anti-inflammatory and antioxidant effects
The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: a systematic review
The primary mechanism is simple